Ex-vivo generation of human red cells for transfusion

Current Opinion in Hematology

Volumn 19, Issue 3, 2012, Pages 163-169

  Anstee, David J ^a,b   Gampel, Alexandra ^a,b   Toye, Ashley M ^a,b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

haematopoietic stem cells; red blood cells; reticulocytes; scaffolds; transfusion

Indexed keywords

CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETICULOCYTE; REVIEW;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 84859829497     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328352240a     Document Type: Review

References (43)

1. Migliaccio AR, Whitsett C, Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol 2009; 16:259-268.
2. Mountford J, Olivier E, Turner M. Prospects for the manufacture of red cells for transfusion. Br J Haematol 2010; 149:22-34.
3. Mazurier C, Douay L, Lapillionne H. Red blood cells from induced pluripotent stem cells: hurdles and developments. Curr Opin Hematol 2011; 18:249-253.
4. Giarattana M-C, Rouard H, Dumont A, Kiger L, et al. Proof of principle for transfusion of in vitro generated red blood cells. Blood 2011; 118:5071-5079.
5. Cogan N, Kupzig S, Parsons SF, Anstee DJ. A robust ex vivo culture system for production of mature human reticulocytes from a single donor. Blood 2011; 118:2096.
6. Griffiths RE, Kupzig S, Cogan N, et al. Plasma membrane loss of maturing reticulocytes occurs through endocytosis of large glycophorin A-containing vacuoles which fuse with autophagosomes before exocytosis. Blood 2011; 118:177.
7. Gasko O, Danon D. Endocytosis and exocytosis in membrane remodelling during reticulocyte maturation. Br J Haematol 1974; 28:463-470.
8. Holroyde CP, Gardner FH. Acquisition of autophagic vacuoles by human erythrocytes. Physiological role of the spleen. Blood 1970; 36:566-575.
9. Tanavde VM, Malehorn MT, Lumkul R, et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002; 30:816-823. (Pubitemid 34831703)
10. Palis J. Ontogeny of erythropoiesis. Curr Opin Hematol 2008; 15:155-161. (Pubitemid 351507565)
11. Anstee DJ. Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS). Transfus Clin Biol 2010; 17:104-109.
12. Chang K-H, Bonig H, Papayannopoulou T. Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells: an overview. Stem Cells Int 2011; 2011:791604.
13. Lapillonne H, Kobari L, Mazurier C, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica 2010; 95:1651-1659.
14. Dias J, Gumenyuk M, Kang H, et al. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev 2011; 20:1639-1647.
15. Szabo E, Rampalli S, Risuefio RM, et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010; 468:521-526.
16. Hiroyama T, Miharad K, Sudo K, et al. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 2008; 3:e1544. doi: 10.1371/journal.pone.0001544. (Pubitemid 351836695)
17. Van den Akker E, Satchwell TJ, Pellegrin S, et al. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34( +) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 2010; 95:1594-1598.
18. Varricchio L, Masselli E, Alfani E, et al. The dominant negative beta isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood 2011; 118:425-436.
19. Rogers HM, Yu X, Wen J, et al. Hypoxia alters progression of the erythroid program. Exp Hematol 2008; 36:17-27. (Pubitemid 350266966)
20. Viaski M, Lefarge X, Chevaleyre J, et al. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo. Exp Hematol 2009; 37:573-584.
21. Tirelli V, Ghinassi B, Migliaccio AR, et al. Phenotype definition of the progenitor cells with erythroid differentiation potential present in human adult blood. Stem Cells Int 2011; 2011:602483.
22. Boitano AE, Wang J, Romeo R, Bouchez LC, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010; 329:1345-1348.
23. Nishino T, Wang C, Mochizuki-Kashio M, et al. Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase. PLoS One 2011; 6:e24298.
24. Guo CJ, Gao Y, Hou D, et al. Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood. World J Stem Cells 2011; 3:43-52.
25. Hosing C, de Lima M, Champlain R, Shpall EJ. Ex-vivo expanded cord blood with mesenchymal stromal cells promotes recovery from cytopenia after cord blood transplant [abstract]. In: Proceedings of the International Society for Cellular Therapy Meeting; Australia, Sydney, October 2011.
26. Timmins NE, Athanasas S, Gunther M, et al. Ultra high yield manufacture of red blood cells from hematopoietic stem cells. Tissue Eng C Methods 2011; 17:1131-1137.
27. Feng Q, Chai C, Jiang XS, et al. Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin. J Biomed Mater Res A 2006; 78:781-791. (Pubitemid 44300032)
28. Chua KN, Chai C, Lee PC, et al. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells. Exp Hematol 2007; 35:771-781. (Pubitemid 46601750)
29. Jozaki T, Aoki K, Mizumoto H, Kajiwara T. In vitro reconstruction of a threedimensional mouse hematopoietic microenvironment in the pore of polyurethane foam. Cytotechnology 2010; 62:531-537.
30. Mortera-Blanco T, Mantalaris A, Bismarck A, et al. Long-term cytokine-free expansion of cord blood mononuclear cells in three-dimensional scaffolds. Biomaterials 2011; 32:9263-9270.
31. Miyoshi H, Ohshima N, Sato C. Three-dimensional culture of mouse bone marrow cells on stroma formed within a porous scaffold: influence of scaffold shape and cryopreservation of the stromal layer on expansion of haematopoietic progenitor cells. J Tissue Eng Regen Med 2011; 5:112-118.
32. Tomimori Y, Takagi M, Yoshida T. The construction of an in vitro threedimensional hematopoietic microenvironment for mouse bone marrow cells employing porous carriers. Cytotechnology 2000; 34:121-130.
33. Braccini A, Wendt D, Jaquiery C, et al. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 2005; 23:1066-1072. (Pubitemid 41377722)
34. Li Y, Ma T, Kniss DA, et al. Human cord cell hematopoiesis in three-dimensional nonwoven fibrous matrices: in vitro simulation of the marrow microenvironment. J Hematother Stem Cell Res 2001; 10:355-368. (Pubitemid 32674114)
35. Tan J, Liu T, Hou L, et al. Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche. Cytotechnology 2010; 62:439-448.
36. Sullenbarger B, Bahng JH, Gruner R, et al. Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 2009; 37:101-110.
37. Perreault J, Lavoie J, Painchaud P, et al. Set-up and routine use of a database of 10,555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients. Vox Sang 2009; 97:61-68.
38. Fujimi A, Matsunaga T, Kobune M, et al. Ex vivo large scale generation of human red blood cells from cord blood CD34 + cells by co-culturing with macrophages. Int J Hematol 2008; 87:339-350.
39. Khodabux CM, Brand A. The use of cord blood for transfusion purposes: current status. Vox Sang 2009; 97:281-293.
40. Khodabux CM, von Lindern JS, van Hilten JA, et al. A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity. Transfusion 2008; 48:1634-1643.
41. Khodabux CM, van Beckhoven JM, Scharenberg JG, et al. Processing cord blood from premature infants into autologous red blood cell products for transfusion. Vox Sang 2011; 100:367-373.
42. Hu Z, Van Rooijen N, Yang YG. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood 2011; 118:5938-5946.
43. Peyrard T, Bardiaux L, Krause C, et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011; 25:206-216.